Synergy Pharma has seen a nice rally in June after a multi-month selloff following the approval of Trulance. The question is whether the biotech will rally in July after closing June at $4.45. The average analyst estimate is that the stock will reach $10.50 including the recent Overweight initiation of Cantor Fitzgerald with a target of $11 while Citigroup downgraded the stock to Sell. The biggest fear being the need to the company to raise more cash as Trulance ramps up prescriptions. Will Synergy rally in July?Note: The forecast will actually end at at the end of the month and not the 29th as listed. Disclosure: No position